IL130375A0 - Di-or triaza-spiro ¬4,5¾ decane derivatives - Google Patents

Di-or triaza-spiro ¬4,5¾ decane derivatives

Info

Publication number
IL130375A0
IL130375A0 IL13037599A IL13037599A IL130375A0 IL 130375 A0 IL130375 A0 IL 130375A0 IL 13037599 A IL13037599 A IL 13037599A IL 13037599 A IL13037599 A IL 13037599A IL 130375 A0 IL130375 A0 IL 130375A0
Authority
IL
Israel
Prior art keywords
triaza
spiro
decane derivatives
decane
derivatives
Prior art date
Application number
IL13037599A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL130375A0 publication Critical patent/IL130375A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13037599A 1998-06-12 1999-06-09 Di-or triaza-spiro ¬4,5¾ decane derivatives IL130375A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98110803 1998-06-12

Publications (1)

Publication Number Publication Date
IL130375A0 true IL130375A0 (en) 2000-06-01

Family

ID=8232113

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13037599A IL130375A0 (en) 1998-06-12 1999-06-09 Di-or triaza-spiro ¬4,5¾ decane derivatives

Country Status (30)

Country Link
US (1) US6642247B2 (hu)
EP (1) EP0963985B1 (hu)
JP (1) JP3369123B2 (hu)
KR (1) KR100393311B1 (hu)
CN (2) CN1229377C (hu)
AR (1) AR019860A1 (hu)
AT (1) ATE234302T1 (hu)
AU (1) AU752835B2 (hu)
BR (1) BR9902653A (hu)
CA (1) CA2274201C (hu)
CO (1) CO5040061A1 (hu)
CZ (1) CZ291323B6 (hu)
DE (1) DE69905798T2 (hu)
DK (1) DK0963985T3 (hu)
ES (1) ES2194402T3 (hu)
HR (1) HRP990187A2 (hu)
HU (1) HUP9901910A3 (hu)
ID (1) ID23306A (hu)
IL (1) IL130375A0 (hu)
MA (1) MA26645A1 (hu)
NO (1) NO312591B1 (hu)
NZ (1) NZ336226A (hu)
PE (1) PE20000540A1 (hu)
PL (1) PL333693A1 (hu)
PT (1) PT963985E (hu)
SG (1) SG83135A1 (hu)
TR (1) TR199901380A2 (hu)
TW (1) TW434241B (hu)
YU (1) YU26799A (hu)
ZA (2) ZA993853B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69923744T2 (de) * 1998-10-23 2006-02-23 Pfizer Inc. 1,3,8-Triazaspiro[4,5] decanon Verbindungen als orl1-receptor Agonisten
PT1491212E (pt) 2002-03-29 2012-11-16 Mitsubishi Tanabe Pharma Corp Medicamento para distúrbios de sono
DE102004014296A1 (de) 2004-03-22 2005-10-06 Grünenthal GmbH Substituierte 1,4,8-Triazaspiro[4.5]decan-2-on-Verbindingen
KR100662191B1 (ko) 2004-12-23 2006-12-27 엘지이노텍 주식회사 질화물 반도체 발광소자 및 그 제조방법
AU2008219980B2 (en) 2007-03-01 2012-01-12 Mitsubishi Tanabe Pharma Corporation Benzimidazole compound and pharmaceutical use thereof
TW201016675A (en) 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof
CN109503582A (zh) * 2018-12-17 2019-03-22 上海合全药物研发有限公司 顺式螺[哌啶并-4,1＇-吡咯并[3,4-c]吡咯]-1-甲酸叔丁酯的合成方法
CN113966337B (zh) * 2020-05-12 2024-01-02 北京广为医药科技有限公司 调节nmda受体活性的化合物、其药物组合物及用途
KR20220022988A (ko) 2020-08-20 2022-03-02 제트스타 주식회사 트랙터용 써레

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63208844A (ja) * 1987-02-26 1988-08-30 Konica Corp 有機着色物質の光褪色防止方法
US5221675A (en) * 1989-12-15 1993-06-22 Abbott Laboratories Aza-spirocyclic compounds that enhance cholinergic neurotransmission
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

Also Published As

Publication number Publication date
AR019860A1 (es) 2002-03-20
CA2274201A1 (en) 1999-12-12
NZ336226A (en) 2000-10-27
TW434241B (en) 2001-05-16
HUP9901910A3 (en) 2001-11-28
DE69905798D1 (de) 2003-04-17
DK0963985T3 (da) 2003-06-23
US20030176701A1 (en) 2003-09-18
MA26645A1 (fr) 2004-12-20
AU752835B2 (en) 2002-10-03
NO992876L (no) 1999-12-13
CA2274201C (en) 2010-02-09
HUP9901910A2 (hu) 2000-04-28
ID23306A (id) 2000-04-05
CN1110497C (zh) 2003-06-04
CN1242367A (zh) 2000-01-26
CN1229377C (zh) 2005-11-30
DE69905798T2 (de) 2004-02-12
NO992876D0 (no) 1999-06-11
SG83135A1 (en) 2001-09-18
CZ291323B6 (cs) 2003-02-12
JP3369123B2 (ja) 2003-01-20
ZA993853B (en) 1999-12-13
PE20000540A1 (es) 2000-07-15
CN1244528A (zh) 2000-02-16
CZ203999A3 (cs) 2000-03-15
ZA993901B (en) 1999-12-13
EP0963985A3 (en) 2001-01-24
CO5040061A1 (es) 2001-05-29
YU26799A (sh) 2002-03-18
AU3498699A (en) 1999-12-23
ATE234302T1 (de) 2003-03-15
EP0963985A2 (en) 1999-12-15
EP0963985B1 (en) 2003-03-12
NO312591B1 (no) 2002-06-03
JP2000026466A (ja) 2000-01-25
KR100393311B1 (ko) 2003-08-02
PT963985E (pt) 2003-06-30
US6642247B2 (en) 2003-11-04
KR20000006135A (ko) 2000-01-25
PL333693A1 (en) 1999-12-20
HU9901910D0 (en) 1999-08-30
TR199901380A3 (tr) 2001-01-22
ES2194402T3 (es) 2003-11-16
TR199901380A2 (xx) 2001-01-22
BR9902653A (pt) 2000-05-02
HRP990187A2 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
DE69941083D1 (en) 12,13-cyclopropan-epothilonderivate
HK1042295A1 (zh) 1h-咪唑並吡啶衍生物
EP1120407A4 (en) CYSTEINE DERIVATIVES
PL349504A1 (en) 1,2-annelated quinoline derivatives
PL345540A1 (en) Thiobenzimidazole derivatives
GB9910384D0 (en) Alpha-ketoamide derivatives
IL143095A0 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
IL130377A0 (en) Diaza-spiro¬3,5¾nonane derivatives
ZA991550B (en) Cyclohexanediole derivatives.
EG23802A (en) 2-Phenylpyran-4-one derivatives
IL130375A0 (en) Di-or triaza-spiro ¬4,5¾ decane derivatives
HK1040991A1 (zh) 2-雜芳基-3，4-二氫-2h-吡咯衍生物
EP1116726A4 (en) ethylamine
GB9827729D0 (en) Thieno-indole derivatives
HUP0102518A3 (en) 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them
IL139276A0 (en) Cyclohexenondioxthio chromanoyl derivatives
HK1042478A1 (zh) 2-氧代-2h-喹啉衍生物
GB2350361B (en) 3,4,5-tricyanophenyl derivatives
GB9825899D0 (en) Stationery
CA84168S (en) Figurine
ZA200101452B (en) 1-H-Imidazopyridine derivatives.
SI1051395T1 (sl) N-hidroksiformamidni derivati
AU134574S (en) Figurine
PL108664U1 (en) Post-card
SI1140835T1 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives